Treatment	Cause	Edge Weight	Shared Publications
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 9: Joint Inflammation and Oxidative Stress as Contributing Factors to COPD Pathogenesis in Rheumatoid Arthritis Patients	0.37965260545905705	153
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 4: NLRP3 Inflammasome-Mediated Inflammatory Dysregulation in COPD Pathogenesis and Therapeutic Targets	0.053763440860215055	10
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 28: Inflammatory Pathways Linking Osteoarthritis and COPD: Shared Mechanisms of Cartilage Destruction and Matrix Degradation	0.05058365758754864	13
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 26: Epigenetic and Inflammatory Regulation of Oxidative Stress and Nitric Oxide Production in COPD Pathogenesis	0.03211009174311927	21
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 16: Unveiling Novel Targets and Immune Mechanisms in COPD Pathogenesis: From Muscle Metabolism to Macrophage Polarization	0.029957203994293864	21
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 10: Natural Bioactive Polyphenols and Flavonoids as Potential Therapeutic Agents in COPD Prevention	0.02510460251046025	12
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 8: Estrogen-Regulated Autophagy and miRNA Networks in Endometriosis-Related COPD Pathogenesis	0.02119460500963391	11
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 23: Hormetic Regulation of Oxidative Stress and Inflammatory Pathways in COPD and Related Ischemic Diseases	0.018779342723004695	12
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 33: Gut Microbiota Dysbiosis and Intestinal Immune Homeostasis Disruption in COPD Pathogenesis	0.012315270935960592	5
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 35: Cardiovascular and Metabolic Comorbidities as Modifiable Risk Factors for COPD Exacerbation	0.010775862068965518	5
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 6: Intrauterine and Chronic Inflammation-Driven Dysregulation of Anti-Inflammatory Responses in COPD Development	0.01050420168067227	5
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 1: TNF Inhibition and Modulation of COPD Inflammatory Profiles in Complex Comorbidities	0.010033444816053512	3
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 25: Wound Healing Dysregulation and Tissue Remodeling as Systemic Influencers of COPD Pathogenesis	0.006944444444444444	2
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 19: Adipose Tissue Inflammation and Metabolic Dysfunction in the Pathogenesis of COPD	0.006493506493506494	2
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 18: Unraveling the Molecular Interplay of Î² Adrenoceptors, Gasotransmitters, and Sulfonation in COPD Pathogenesis	0.005964214711729622	3
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 32: Autoimmune and Autoinflammatory Conditions as Indicators of COPD Risk and Disease Progression	0.0045045045045045045	3
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 11: Gut-Respiratory Axis: Inflammatory Disorders and Immune Dysregulation in COPD Pathogenesis	0.0037105751391465678	2
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 5: Environmental Toxicants and Cyclooxygenase Inhibition in Gastrointestinal COPD Pathways	0.003115264797507788	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 39: Renal Dysfunction and Inflammation as Critical Modulators of COPD Pathogenesis and Exacerbation Risk	0.003115264797507788	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 17: Eicosanoid Dysregulation and Cox Inhibition: Unveiling the Complex Links between COPD and Cardiovascular, Gastrointestinal, and Metabolic Disorders	0.003067484662576687	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 38: Liver Damage, Inflammation, and Fibrogenesis as Systemic Consequences in COPD Pathogenesis	0.0028011204481792717	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 31: Cardiac Dysfunction and Inflammation: A Novel Link to COPD Pathogenesis and Comorbidity	0.002793296089385475	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 7: Congenital and Interstitial Lung Diseases as Modifiers of Emphysema and Fibrosis in COPD	0.001996007984031936	1
COPD Treatment Cluster 17: Targeting TL1A-DR3 Signaling and IRAK4 Activity for Inflammatory Control in COPD and RA	COPD Cause Cluster 36: Elucidating the Complex Genetic and Epithelial Mechanisms Underlying COPD Susceptibility and Progression	0.0009775171065493646	1
